A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells (RBCs) that goes beyond traditional haemoglobin assays. While haemoglobin levels measure ...

索乐匹尼布是由和黄医药自主研发的一款口服选择性Syk抑制剂，在研适应症包括免疫性血小板减少症（ITP）、温抗体型自身免疫溶血性贫血（WAIHA ...

The global warm autoimmune hemolytic anemia (waiha) treatment industry is worth USD 638.96 Million in the year 2023 and is expected to reach USD 1598 Million by the year 2033 at a CAGR of 9.6% between ...

Despite a solid season, the Vikings are narrow favorites against the Packers, suggesting a tight, historically significant matchup with two powerhouses. Christmas dinner injury forces golf’s ...

A recent multicentre study has highlighted the potential of venetoclax combined with decitabine as an effective first-line treatment for older patients with acute myeloid leukaemia (AML) who are ...

Based on these results, this dose level was considered partially ineffective, and the dose was escalated. Three patients received 20 mg fixed dose every 4 weeks (Figure 2), two patients with CAD and ...